TYME Tyme Technologies Inc.

1.03
+0.03  (+3%)
Previous Close 1
Open 1.01
Price To Book 9.36
Market Cap 115,309,465
Shares 111,950,937
Volume 381,598
Short Ratio
Av. Daily Volume 1,057,636

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 presentation at ESMO September 29, 2019. 12:00 PM CET.
SM-88
Pancreatic cancer
Phase 2 presentation at ESMO September 30, 2019. 12:00 PM CET.
SM-88
Prostate cancer
Phase 1/2 initiation announced May 23, 2019.
SM-88
Ewing’s sarcoma

Latest News

  1. TYME Announces Abstracts Selected for Presentation at the European Society of Medical Oncology Congress 2019
  2. Tyme Technologies to Present at BTIG Biotechnology Conference on August 12th, 2019
  3. TYME Provides Business Update and Reports First Quarter Fiscal 2020 Financial and Operating Results
  4. TYME Announces Abstracts Selected for Presentation at the AACR Special Conference on Pancreatic Cancer
  5. Tyme Technologies to Present at the 39th Annual Canaccord Genuity Growth Conference on August 7th, 2019
  6. TYME Technologies Announces New Collaboration with NYU Langone to Advance TYME’s Cancer Metabolism-Based Therapy, SM-88
  7. REMINDER - TYME Presents Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends in Patients with Advanced Pancreatic Cancer
  8. Tyme Technologies News: Why TYME Stock Is Rocketing
  9. Tyme Technologies stock soars on heavy volume after upbeat update to cancer treatment study
  10. TYME Presents Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends in Patients with Advanced Pancreatic Cancer
  11. Will Tyme Technologies, Inc.'s (NASDAQ:TYME) Earnings Grow Over The Next Few Years?
  12. Weekly CFO Buys Highlight
  13. TYME Announces Abstract Selected for Presentation at the European Society for Medical Oncology 21st World Congress on Gastrointestinal Cancer 2019
  14. TYME Provides Business Update and Reports Fourth Quarter and Fiscal Year 2019 Financial and Operating Results
  15. The Tyme Technologies (NASDAQ:TYME) Share Price Is Down 83% So Some Shareholders Are Rather Upset
  16. Tyme Technologies to Present at the Jefferies 2019 Global Healthcare Conference on June 7, 2019
  17. Tyme Technologies To Host a Conference Call for the Fourth Quarter and Fiscal Year 2019 Financial and Operating Results on May 29, 2019
  18. TYME and The Joseph Ahmed Foundation Announce Initiation of the HopES Phase II Trial Evaluating the Potential Benefits of SM-88 for Patients with High-Risk Sarcomas
  19. TYME Announces Notification of Issuance of U.S. Patent Covering SM-88 Single Agent Treatment for Cancers
  20. Tyme Technologies to Participate at the Oppenheimer Oncology Insight Summit on May 16th